Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Kerscher

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Problems in Dermatology|January 1, 1993
Suppression of induced inflammation in manM J Kerscher
The Clinical Investigator|February 1, 1992
Treatment of atopic eczema with evening primrose oil: rationale and clinical resultsM J Kerscher, H C Korting
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1992
Comparative atrophogenicity potential of medium and highly potent topical glucocorticoids in cream and ointment according to ultrasound analysisM J Kerscher, H C Korting
Acta Dermato-Venereologica|January 1, 1992
Topical glucocorticoids of the non-fluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasoundM J Kerscher, H C Korting
Journal of the American Academy of Dermatology|July 1, 1992
Topical glucocorticoids with improved benefit/risk ratio: do they exist?H C Korting, M J Kerscher, M Schäfer-Korting
International Journal of Clinical Pharmacology and Therapeutics|April 1, 1995
In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and newM J Kerscher, H Hart, H C Korting, et al.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1996
0.05% clobetasol 17-propionate cream and ointment but not the corresponding 0.1% triamcinolone acetonide preparations increase skin surface roughness: a possible dissociation of unwanted epidermal and dermal effectsM J Kerscher, H C Korting, L Mehringer, et al.
Ultrasound in Medicine & Biology|January 1, 1997
Sonographic determination of cutaneous and subcutaneous fibrosis after accidental exposure to ionising radiation in the course of the Chernobyl nuclear power plant accidentP Gottlöber, M J Kerscher, H C Korting, et al.
Clinical Pharmacology and Therapeutics|October 1, 1993
Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoidsM Schäfer-Korting, H C Korting, M J Kerscher, et al.
The British Journal of Dermatology|March 21, 2002
Do we alter ultraviolet sensitivity in vivo with stratum corneum rehydration? A pilot study and review of the literatureS C Behrens-Williams, D Kraus, T Reuther, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Problems in Dermatology|January 1, 1993
Suppression of induced inflammation in manM J Kerscher
The Clinical Investigator|February 1, 1992
Treatment of atopic eczema with evening primrose oil: rationale and clinical resultsM J Kerscher, H C Korting
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1992
Comparative atrophogenicity potential of medium and highly potent topical glucocorticoids in cream and ointment according to ultrasound analysisM J Kerscher, H C Korting
Acta Dermato-Venereologica|January 1, 1992
Topical glucocorticoids of the non-fluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasoundM J Kerscher, H C Korting
Journal of the American Academy of Dermatology|July 1, 1992
Topical glucocorticoids with improved benefit/risk ratio: do they exist?H C Korting, M J Kerscher, M Schäfer-Korting
International Journal of Clinical Pharmacology and Therapeutics|April 1, 1995
In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and newM J Kerscher, H Hart, H C Korting, et al.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1996
0.05% clobetasol 17-propionate cream and ointment but not the corresponding 0.1% triamcinolone acetonide preparations increase skin surface roughness: a possible dissociation of unwanted epidermal and dermal effectsM J Kerscher, H C Korting, L Mehringer, et al.
Ultrasound in Medicine & Biology|January 1, 1997
Sonographic determination of cutaneous and subcutaneous fibrosis after accidental exposure to ionising radiation in the course of the Chernobyl nuclear power plant accidentP Gottlöber, M J Kerscher, H C Korting, et al.
Clinical Pharmacology and Therapeutics|October 1, 1993
Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoidsM Schäfer-Korting, H C Korting, M J Kerscher, et al.
The British Journal of Dermatology|March 21, 2002
Do we alter ultraviolet sensitivity in vivo with stratum corneum rehydration? A pilot study and review of the literatureS C Behrens-Williams, D Kraus, T Reuther, et al.
Pageof 1